Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Cellectar Biosciences, Inc. (NV4.F)

Compare
0.2600
-0.0480
(-15.58%)
As of 8:12:01 AM GMT+1. Market Open.

Valuation Measures

Annual Monthly
Currency in EUR Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 12.25M 68.69M 83.70M 118.75M 30.76M 24.79M
Enterprise Value -7.00M 48.63M 62.77M 116.02M 15.37M 21.77M
Trailing P/E -- -- -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales -- -- -- -- -- --
Price/Book 9.58 7.84 9.04 -- -- --
Enterprise Value/Revenue -- -- -- -- -- --
Enterprise Value/EBITDA -- -- -- -- -1.23 -2.32
9/30/2023 - 12/8/2006

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -109.57%
Return on Equity (ttm) -474.63%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -51.29M
Net Income Avi to Common (ttm) -50.11M
Diluted EPS (ttm) -1.3500
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 34.26M
Total Cash Per Share (mrq) 0.74
Total Debt (mrq) 512.75k
Total Debt/Equity (mrq) 3.10%
Current Ratio (mrq) 1.77
Book Value Per Share (mrq) 0.04

Cash Flow Statement

Operating Cash Flow (ttm) -46.27M
Levered Free Cash Flow (ttm) -25.08M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52 Week Range 3 -92.47%
S&P 500 52-Week Change 3 18.02%
52 Week High 3 3.8800
52 Week Low 3 0.1640
50-Day Moving Average 3 0.2395
200-Day Moving Average 3 1.5559

Share Statistics

Avg Vol (3 month) 3 14.25k
Avg Vol (10 day) 3 9.66k
Shares Outstanding 5 46.08M
Implied Shares Outstanding 6 51.51M
Float 8 45.33M
% Held by Insiders 1 1.64%
% Held by Institutions 1 11.06%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 1:10
Last Split Date 3 7/22/2022

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.